Kevin Finney - 28 Jan 2025 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Role
Director
Signature
/s/ Edward Berg, Attorney-in-Fact for Kevin Finney
Issuer symbol
VXRT
Transactions as of
28 Jan 2025
Net transactions value
$0
Form type
4
Filing time
29 Jan 2025, 20:05:50 UTC
Next filing
16 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VXRT Common Stock Award $0 +32,000 $0.000000 32,000 28 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VXRT Stock Option (right to buy) Award $0 +190,800 $0.000000 190,800 28 Jan 2025 Common Stock 190,800 $0.7522 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of shares upon vesting of restricted stock units. One third of the shares underlying the award shall vest on each anniversary of the grant date, so that the restricted stock units would be fully vested on the third anniversary of the grant date.
F2 The shares subject to this option shall vest annually over three years from the vesting commencement date of January 28, 2025, the date of the grantee's appointment as a director of Vaxart, Inc.

Remarks:

Exhibit 24 - Power of Attorney